Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yael Hacohen

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Continuum (Minneapolis, Minn.)|August 1, 2024
Pediatric Autoimmune Neurologic DisordersYael Hacohen
Neurology|February 11, 2022
New Evidence for Epstein-Barr Virus Infection as a Cause of Multiple SclerosisYael Hacohen, Olga Ciccarelli
Current Treatment Options in Neurology|January 24, 2019
Treatment Approaches for MOG-Ab-Associated Demyelination in ChildrenYael Hacohen, Brenda Banwell
Neurology|June 13, 2023
Treatment De-escalation in AQP4-Ab Neuromyelitis Optica Spectrum DisorderYael Hacohen, Carmen Tur
Neurology|April 27, 2018
Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorderYael Hacohen, Jacqueline Palace
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|February 19, 2018
Autoimmune neurological disorders-does the age matter?Yael Hacohen, Angela Vincent
Neurology|August 27, 2024
Testing Validity of the MOGAD Diagnostic Criteria in Children and AdultsThomas Rossor, Yael Hacohen
Neurology|October 5, 2021
Multiple Sclerosis in Children and Adults: Does Age Matter?Yael Hacohen, Arman Eshaghi
Neurology|May 5, 2025
Increased Risk of Misdiagnosis and Treatment Complication in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseRomain Marignier, Yael Hacohen
Developmental Medicine and Child Neurology|October 9, 2019
Myelin oligodendrocyte glycoprotein antibodies associated disease: how important are B cells?Yael Hacohen, Romain Marignier
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Continuum (Minneapolis, Minn.)|August 1, 2024
Pediatric Autoimmune Neurologic DisordersYael Hacohen
Neurology|February 11, 2022
New Evidence for Epstein-Barr Virus Infection as a Cause of Multiple SclerosisYael Hacohen, Olga Ciccarelli
Current Treatment Options in Neurology|January 24, 2019
Treatment Approaches for MOG-Ab-Associated Demyelination in ChildrenYael Hacohen, Brenda Banwell
Neurology|June 13, 2023
Treatment De-escalation in AQP4-Ab Neuromyelitis Optica Spectrum DisorderYael Hacohen, Carmen Tur
Neurology|April 27, 2018
Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorderYael Hacohen, Jacqueline Palace
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|February 19, 2018
Autoimmune neurological disorders-does the age matter?Yael Hacohen, Angela Vincent
Neurology|August 27, 2024
Testing Validity of the MOGAD Diagnostic Criteria in Children and AdultsThomas Rossor, Yael Hacohen
Neurology|October 5, 2021
Multiple Sclerosis in Children and Adults: Does Age Matter?Yael Hacohen, Arman Eshaghi
Neurology|May 5, 2025
Increased Risk of Misdiagnosis and Treatment Complication in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseRomain Marignier, Yael Hacohen
Developmental Medicine and Child Neurology|October 9, 2019
Myelin oligodendrocyte glycoprotein antibodies associated disease: how important are B cells?Yael Hacohen, Romain Marignier
Pageof 15